Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

703 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Right To Know Prevails Over Scientific Uncertainty: Madras High Court Upholds Microplastics Labelling Requirement

    In a significant ruling between Food Safety and Standards Authority of India v. G. Subramania Koushik & Ors. addressing consumer awareness and food safety, the Madras High Court has upheld its earlier directions requiring precautionary labelling on plastic/PET-bottled drinking water and sugar and salt sold in plastic packaging, indicating the possible presence of microplastics and nanoplastics. The decision highlights the importance of consumer disclosure, particularly where scientific research has identified potential health concerns but the precise extent of the associated risks remains under investigation.
    IndiaConsumer Protection
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Telemedicine & Law – An Indian Perspective

    Telemedicine basically means "healing at a distance". It is great for both patients and medical assistance provider. That there is no one definitive definition of telemedicine – a 2007 study...
    IndiaFood, Drugs, Healthcare, Life Sciences
Khurana & Khurana, Advocates and IP Attorneys
Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Post-Acquisition Indemnity Failures: What VPS Healthcare’s Rs15.86 Crore Legal Battle Teaches Dealmakers

    VPS Healthcare’s acquisition of Rockland Hospitals offers a cautionary tale in M&A structuring. A seven-year enforcement battle over a disclosed ₹10 crore EY arbitration claim exposed deep structural weaknesses...
    IndiaCorporate/Commercial Law
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Legalaxy - September 2023

    Securities and Exchange Board of India ("SEBI"), in its board meeting held on June 28, 2023, had, inter alia, approved to reduce the time taken for listing of specified securities after the closure of public issue...
    IndiaCorporate/Commercial Law
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    Checking The Pulse Recent Legal Developments In The Indian Healthcare And Pharma Sector

    Over the past couple of months, the Central Drugs Standard Control Organisation has been actively streamlining licensing and approval requirements for pharmaceutical companies...
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    From Experiment To Enforcement: How India Regulates Testing And Clinical Research

    Clinical Trials have been critical to the healthcare sector, serving as the cornerstone of drug development and medical device safety. Without Clinical Trials, it would be impossible to characterize the benefits...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Argus Partners
    Argus Partners
  • Article

    Lifesciences And Healthcare Newsletter | July 2025

    Welcome to the July 2025 edition of our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry and its impact on the various stakeholders.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    印度全境封锁(lockdown)21天!回顾印度的疫情防控措施

    截至3月24日,根据印度卫生部统计的信息,印度境内共确诊了470个新冠肺炎病例(据某些媒体报道已经确诊超过500人),39例治愈,9例死亡。
    IndiaGovernment, Public Sector
    Dentons
    Dentons
  • Article

    Data Exclusivity – The Indian Perspective

    Under Special 301 of the U.S. Trade Act of 1974 India has been put on the ‘PRIORITY WATCH LIST’ of USTR (United States Trade Representative) for failing to provide an adequate level of protection or enforcement and market access for persons relying on Intellectual Property protection.
    IndiaEmployment and HR
    Lex Orbis
    Lex Orbis
  • Article

    Delhi High Court Vacates Injunction, Holds 'A TO Z' Descriptive For Multivitamin Products

    Can a pharmaceutical giant's two-decade-old brand name ‘A TO Z' command exclusive rights over those three terms in the multivitamin market? And what happens when a smaller competitor enters with a composite mark containing the same alphabetical endpoints, embedded within an entirely different word?
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Checking The Pulse – Recent Legal Developments In The Indian Healthcare And Pharma Sector

    India's healthcare, pharmaceutical, and medical devices sectors have witnessed significant regulatory and policy developments from April to May 2026, including the nationwide expansion of mental healthcare services, the launch of the JANANI digital platform for maternal and child healthcare, and proposed amendments to medical device regulations.
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Checking The Pulse – Recent Legal Developments In The Indian Healthcare And Pharma Sector

    Over the past couple of months, the National Health Authority has taken active steps to successfully implement the Ayushman Bharat Digital Mission and drive the cause of digital health in India forward.
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    An Elaborative Overview On: Legislations Around The World Comprising The Data Privacy And Protection Rules

    Meta Title: - the purpose is to write and introduce on the matter of data protection acts around the world through legislation is to give a brief about the acts and by telling the site...
    IndiaPrivacy
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Food Safety & Packaging Rules For Health Supplements, Nutraceuticals, Food For Special Dietary Use, Food For Special Medical Purposes, Functional Food And Novel Food

    The Food Safety and Standards Authority of India had notified the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    Insurance Regulatory Round-up: 2020

    With the widespread impact of the COVID-19 pandemic and several regulatory changes being introduced (as well as proposed) by the Insurance Regulatory and Development Authority of India.
    IndiaCoronavirus (COVID-19)
    Tuli & Co
    Tuli & Co
  • Article

    The Dichotomy Of IPR Protection And Social Welfare- An Analysis Of The Indian Patents Act With Respect To The Pharmaceutical Industry

    Intellectual Property Rights, in the simplest of terms, refer to rights over creation of the mind. In a world where knowledge economies are on the rise, ...
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    GST 2.0: What The 56th Council Meeting Means For Businesses

    For investors, it strengthens India's reputation as a market steadily moving towards international best practices, reducing tax friction and boosting confidence in long-term capital deployment
    IndiaTax
    HSA Advocates
    HSA Advocates
  • Article

    India Puts 42 Non-Scheduled Cancer Drugs Under Price Control

    On February 27, 2019, the National Pharmaceutical Pricing Authority or NPPA capped trade margins of 42 non-scheduled cancer drugs to curb profiteering on vital medicines notified in the Standing Order.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    G20 New Delhi Agreement : Advancing ESG On The Global Stage

    As world leaders converged upon New Delhi for the latest G20 summit, they brought with them not just their nations' hopes and aspirations...
    IndiaStrategy
    Dhir & Dhir Associates
    Dhir & Dhir Associates
  • Article

    Life Sciences And Healthcare Newsletter | April 2026

    India's life sciences and healthcare sector saw significant regulatory shifts in April 2026, including proposed decriminalization of minor violations, new medical device testing fees, and streamlined foreign training requirements for healthcare professionals. Courts also delivered key rulings on pharmaceutical trademark disputes, reinforcing stricter standards for drug name similarity.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Showing 661–680 of 703 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics